# カーディオライト 第一

> Prescription product approved in Japan and listed on the NHI drug price list (YJ code 4300439D1024). Nifuji Pharma sources it for licensed healthcare providers, institutions, and distributors; availability, documentation, and export eligibility are confirmed on inquiry.

- **YJ code:** 4300439D1024
- **Product name (Japanese):** カーディオライト 第一
- **Active ingredient:** テトラキスメトキシイソブチルイソニトリル銅（Ｉ）四フッ化ホウ酸
- **Strength / unit:** １回分
- **Route:** Injection (注射薬)
- **Therapeutic category:** 43 Radiopharmaceuticals (放射性医薬品) › 430 Radiopharmaceuticals (放射性医薬品)
- **Manufacturer:** PDRadiopharma (ＰＤＲファーマ)
- **NHI price (reference only):** JPY 30307 per １回分
- **Regulatory status:** Approved in Japan; listed on the NHI drug price list
- **Web page:** https://www.nifujipharma.com/drugs/4300439D1024
- **JSON:** https://www.nifujipharma.com/api/drugs/4300439D1024

## How to request a quotation

Submit the contact form with the product name, quantity, and destination country: https://www.nifujipharma.com/?product=%E3%82%AB%E3%83%BC%E3%83%87%E3%82%A3%E3%82%AA%E3%83%A9%E3%82%A4%E3%83%88%20%E7%AC%AC%E4%B8%80%20%2F%20YJ%204300439D1024#contact

Quotes are for qualified business customers only (licensed healthcare providers, medical institutions, distributors). Payment is by bank transfer in Japanese Yen. Product collection typically takes 2-4 weeks after order confirmation, followed by export procedures and shipping.